Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Novartis

www.novartis.com

Forum 1
Novartis Campus
Basel
CH-4056
Switzerland

+41 61 324 11 11

Activities

Training & Education | Manufacturing | Drug Delivery | Research & Development | Pharmaceutical

Related Companies

  • Gerresheimer
  • Romaco Holding GmbH
  • Titan Enterprises
  • Icrom SRL
  • TrakCel
  • Huber
  • Nanoform
  • GEA Pharma and Healthcare
  • Starlab
  • Adare Pharma Solutions
  • Beamex
  • NSF
  • Burkert Fluid Control Systems
  • Envair Technology
  • Biopharma Group
  • Asynt
  • PCI Pharma Services
  • Watson Marlow Fluid Technology Solutions
  • Solvias
  • Labtex

Related Content

Made in Switzerland: blockchain enabled healthcare
Made in Switzerland: blockchain enabled healthcare
Sterling acquires API manufacturing facility
Sterling acquires API manufacturing facility
Therapeutic: iptacopan for paroxysmal nocturnal haemoglobinuria
Therapeutic: iptacopan for paroxysmal nocturnal haemoglobinuria
Novartis and MMV move to Phase III study to treat uncomplicated malaria
Novartis and MMV move to Phase III study to treat uncomplicated malaria
Therapeutic: tislelizumab for oncology
Therapeutic: tislelizumab for oncology
Therapeutic: leniolisib for APDS
Therapeutic: leniolisib for APDS
Sterling Pharma Solutions acquires Novartis Facility in Ireland
Sterling Pharma Solutions acquires Novartis Facility in Ireland
Therapeutic: inclisiran for hypercholesterolaemia
Therapeutic: inclisiran for hypercholesterolaemia
Novartis to fund protein degrader therapy research
Novartis to fund protein degrader therapy research
Therapeutics: osilodrostat for Cushing’s disease
Therapeutics: osilodrostat for Cushing’s disease
Novartis to revamp manufacturing with the help of Amazon
Novartis to revamp manufacturing with the help of Amazon
Novartis opens facility for innovative cell and gene therapies in Switzerland
Novartis opens facility for innovative cell and gene therapies in Switzerland
Chinese CDMO purchases former Novartis API facility
Chinese CDMO purchases former Novartis API facility
AveXis chooses BIA Separations to support gene therapy pipeline
AveXis chooses BIA Separations to support gene therapy pipeline
Lonza to buy sterile drug product fill-finish facility from Novartis
Lonza to buy sterile drug product fill-finish facility from Novartis
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company